BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 24236457)

  • 21. Melanoma differentiation-associated gene-7, MDA-7/IL-24, selectively induces growth suppression, apoptosis in human hepatocellular carcinoma cell line HepG2 by replication-incompetent adenovirus vector.
    Wang CJ; Xue XB; Yi JL; Chen K; Zheng JW; Wang J; Zeng JP; Xu RH
    World J Gastroenterol; 2006 Mar; 12(11):1774-9. PubMed ID: 16586551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer terminator viruses (CTV): A better solution for viral-based therapy of cancer.
    Emdad L; Das SK; Wang XY; Sarkar D; Fisher PB
    J Cell Physiol; 2018 Aug; 233(8):5684-5695. PubMed ID: 29278667
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dual cancer-specific targeting strategy cures primary and distant breast carcinomas in nude mice.
    Sarkar D; Su ZZ; Vozhilla N; Park ES; Gupta P; Fisher PB
    Proc Natl Acad Sci U S A; 2005 Sep; 102(39):14034-9. PubMed ID: 16172403
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bcl-2 and Bcl-x(L) differentially protect human prostate cancer cells from induction of apoptosis by melanoma differentiation associated gene-7, mda-7/IL-24.
    Lebedeva IV; Sarkar D; Su ZZ; Kitada S; Dent P; Stein CA; Reed JC; Fisher PB
    Oncogene; 2003 Nov; 22(54):8758-73. PubMed ID: 14647471
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of pancreatic carcinoma growth by adenovirus-mediated human interleukin-24 expression in animal model.
    Pan X; Sheng W; Zhu Q; Xie Y; Ye Z; Xiang J; Li D; Yang J
    Cancer Biother Radiopharm; 2008 Aug; 23(4):425-34. PubMed ID: 18771346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bcl-xL inhibition by molecular-targeting drugs sensitizes human pancreatic cancer cells to TRAIL.
    Hari Y; Harashima N; Tajima Y; Harada M
    Oncotarget; 2015 Dec; 6(39):41902-15. PubMed ID: 26506422
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Strong antitumor efficacy of a pancreatic tumor-targeting oncolytic adenovirus for neuroendocrine tumors.
    Yamamoto Y; Nagasato M; Rin Y; Henmi M; Ino Y; Yachida S; Ohki R; Hiraoka N; Tagawa M; Aoki K
    Cancer Med; 2017 Oct; 6(10):2385-2397. PubMed ID: 28941156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acquired and innate resistance to the cancer-specific apoptosis-inducing cytokine, mda-7/IL-24: not insurmountable therapeutic problems.
    Sarkar D; Dent P; Curiel DT; Fisher PB
    Cancer Biol Ther; 2008 Jan; 7(1):109-12. PubMed ID: 18277093
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ceramide plays a prominent role in MDA-7/IL-24-induced cancer-specific apoptosis.
    Sauane M; Su ZZ; Dash R; Liu X; Norris JS; Sarkar D; Lee SG; Allegood JC; Dent P; Spiegel S; Fisher PB
    J Cell Physiol; 2010 Mar; 222(3):546-55. PubMed ID: 19937735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sulindac enhances adenoviral vector expressing mda-7/IL-24-mediated apoptosis in human lung cancer.
    Oida Y; Gopalan B; Miyahara R; Inoue S; Branch CD; Mhashilkar AM; Lin E; Bekele BN; Roth JA; Chada S; Ramesh R
    Mol Cancer Ther; 2005 Feb; 4(2):291-304. PubMed ID: 15713900
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ionizing radiation enhances therapeutic activity of mda-7/IL-24: overcoming radiation- and mda-7/IL-24-resistance in prostate cancer cells overexpressing the antiapoptotic proteins bcl-xL or bcl-2.
    Su ZZ; Lebedeva IV; Sarkar D; Emdad L; Gupta P; Kitada S; Dent P; Reed JC; Fisher PB
    Oncogene; 2006 Apr; 25(16):2339-48. PubMed ID: 16331261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combinatorial treatment of non-small-cell lung cancers with gefitinib and Ad.mda-7 enhances apoptosis-induction and reverses resistance to a single therapy.
    Emdad L; Lebedeva IV; Su ZZ; Gupta P; Sarkar D; Settleman J; Fisher PB
    J Cell Physiol; 2007 Feb; 210(2):549-59. PubMed ID: 17111370
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced anti-tumor activity by the combination of a conditionally replicating adenovirus mediated interleukin-24 and dacarbazine against melanoma cells via induction of apoptosis.
    Jiang G; Liu YQ; Wei ZP; Pei DS; Mao LJ; Zheng JN
    Cancer Lett; 2010 Aug; 294(2):220-8. PubMed ID: 20189296
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular target-based therapy of pancreatic cancer.
    Lebedeva IV; Sarkar D; Su ZZ; Gopalkrishnan RV; Athar M; Randolph A; Valerie K; Dent P; Fisher PB
    Cancer Res; 2006 Feb; 66(4):2403-13. PubMed ID: 16489047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potent antitumor activity of oncolytic adenovirus expressing mda-7/IL-24 for colorectal cancer.
    Zhao L; Gu J; Dong A; Zhang Y; Zhong L; He L; Wang Y; Zhang J; Zhang Z; Huiwang J; Qian Q; Qian C; Liu X
    Hum Gene Ther; 2005 Jul; 16(7):845-58. PubMed ID: 16000066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Conditionally replicative adenovirus-based mda-7/IL-24 expression enhances sensitivity of colon cancer cells to 5-fluorouracil and doxorubicin.
    Xu J; Mo Y; Wang X; Liu J; Zhang X; Wang J; Hu L; Yang C; Chen L; Wang Y
    J Gastroenterol; 2013 Feb; 48(2):203-13. PubMed ID: 22820863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel REIC/Dkk-3-encoding adenoviral vector as a promising therapeutic agent for pancreatic cancer.
    Sawahara H; Shiraha H; Uchida D; Kato H; Nagahara T; Iwamuro M; Kataoka J; Horiguchi S; Watanabe M; Sakaguchi M; Takaki A; Nouso K; Nasu Y; Kumon H; Okada H
    Cancer Gene Ther; 2016 Aug; 23(8):278-83. PubMed ID: 27468808
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adenovirus vector-mediated Gli1 siRNA induces growth inhibition and apoptosis in human pancreatic cancer with Smo-dependent or Smo-independent Hh pathway activation in vitro and in vivo.
    Guo J; Gao J; Li Z; Gong Y; Man X; Jin J; Wu H
    Cancer Lett; 2013 Oct; 339(2):185-94. PubMed ID: 23791879
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The in vitro and in vivo antitumor activity of adenovirus-mediated interleukin-24 expression for laryngocarcinoma.
    Liu J; Sheng W; Xie Y; Shan Y; Miao J; Xiang J; Yang J
    Cancer Biother Radiopharm; 2010 Feb; 25(1):29-38. PubMed ID: 20187794
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeted virus replication plus immunotherapy eradicates primary and distant pancreatic tumors in nude mice.
    Sarkar D; Su ZZ; Vozhilla N; Park ES; Randolph A; Valerie K; Fisher PB
    Cancer Res; 2005 Oct; 65(19):9056-63. PubMed ID: 16204080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.